Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Bianco

Showing results (181-190 of 324) with videos related to

Pageof 33
Sort By:
Thymus|January 1, 1988
Effect of thymic extract 'thymostimulin' on the incidence of infections and myelotoxicity during adjuvant chemotherapy for breast cancerR V Iaffaioli, G Frasci, G Tortora, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
Phase I study of epirubicin plus vinorelbine with or without G-CSF in advanced non-small cell lung cancerC Gridelli, S De Placido, R Pepe, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1996
Phase I study of ifosfamide plus high-dose epirubicin in advanced non-small-cell lung cancerC Gridelli, A Rossi, P Incoronato, et al.
European Journal of Gynaecological Oncology|January 1, 1991
Alpha 2b interferon (IFN) by intraperitoneal administration via temporary catheter in ovarian cancer. Preliminary dataR V Iaffaioli, G Frasci, G Facchini, et al.
Lancet (London, England)|November 12, 1988
Adjuvant therapy with tamoxifen in operable breast cancer. 10 year results of the Naples (GUN) studyA R Bianco, S De Placido, C Gallo, et al.
Immunology Letters|February 1, 1997
Extracellular adenosine 5' triphosphate involvement in the death of LAK-engaged human tumor cells via P2X-receptor activationP Correale, P Tagliaferri, R Guarrasi, et al.
Oncogene|February 27, 1997
The RIalpha subunit of protein kinase A (PKA) binds to Grb2 and allows PKA interaction with the activated EGF-receptorG Tortora, V Damiano, C Bianco, et al.
British Journal of Cancer|March 6, 2008
Inhibition of mTOR pathway by everolimus cooperates with EGFR inhibitors in human tumours sensitive and resistant to anti-EGFR drugsR Bianco, S Garofalo, R Rosa, et al.
Heart Rhythm O2|June 6, 2024
Sex differences in achieving guideline-recommended heart rate control among a large sample of patients at risk for sudden cardiac arrestValentina Kutyifa, Ashley E Burch, Birgit Aßmus, et al.
British Journal of Cancer|April 28, 2005
A phase II study of biweekly oxaliplatin plus infusional 5-fluorouracil and folinic acid (FOLFOX-4) as first-line treatment of advanced gastric cancer patientsF De Vita, M Orditura, E Matano, et al.
Pageof 33

Showing results (181-190 of 324) with videos related to

Sort By:
Pageof 33
Thymus|January 1, 1988
Effect of thymic extract 'thymostimulin' on the incidence of infections and myelotoxicity during adjuvant chemotherapy for breast cancerR V Iaffaioli, G Frasci, G Tortora, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
Phase I study of epirubicin plus vinorelbine with or without G-CSF in advanced non-small cell lung cancerC Gridelli, S De Placido, R Pepe, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1996
Phase I study of ifosfamide plus high-dose epirubicin in advanced non-small-cell lung cancerC Gridelli, A Rossi, P Incoronato, et al.
European Journal of Gynaecological Oncology|January 1, 1991
Alpha 2b interferon (IFN) by intraperitoneal administration via temporary catheter in ovarian cancer. Preliminary dataR V Iaffaioli, G Frasci, G Facchini, et al.
Lancet (London, England)|November 12, 1988
Adjuvant therapy with tamoxifen in operable breast cancer. 10 year results of the Naples (GUN) studyA R Bianco, S De Placido, C Gallo, et al.
Immunology Letters|February 1, 1997
Extracellular adenosine 5' triphosphate involvement in the death of LAK-engaged human tumor cells via P2X-receptor activationP Correale, P Tagliaferri, R Guarrasi, et al.
Oncogene|February 27, 1997
The RIalpha subunit of protein kinase A (PKA) binds to Grb2 and allows PKA interaction with the activated EGF-receptorG Tortora, V Damiano, C Bianco, et al.
British Journal of Cancer|March 6, 2008
Inhibition of mTOR pathway by everolimus cooperates with EGFR inhibitors in human tumours sensitive and resistant to anti-EGFR drugsR Bianco, S Garofalo, R Rosa, et al.
Heart Rhythm O2|June 6, 2024
Sex differences in achieving guideline-recommended heart rate control among a large sample of patients at risk for sudden cardiac arrestValentina Kutyifa, Ashley E Burch, Birgit Aßmus, et al.
British Journal of Cancer|April 28, 2005
A phase II study of biweekly oxaliplatin plus infusional 5-fluorouracil and folinic acid (FOLFOX-4) as first-line treatment of advanced gastric cancer patientsF De Vita, M Orditura, E Matano, et al.
Pageof 33